Articles related to PTSD

This 22-year study provides a detailed examination of the relationship between antihypertensive medications and PTSD incidence in trauma victims. Physicians interested in the potential preventive role of these medications in PTSD are invited to delve into the findings and implications for future research.

Recent phase 3 clinical trials have demonstrated the eye-opening potential of MDMA in the treatment of PTSD when paired with psychotherapy, providing a new method of patient care.

The preliminary findings suggest a potential new direction for managing chronic pain in PTSD, inviting further research and consideration in the clinical field.

The number and quality of available studies on ketamine plus psychotherapy are limited because of the newness of the therapy. However, in the 4 studies deemed eligible for review, ketamine plus psychotherapy—regardless of protocol—was associated with significant symptom reduction.

In comparing PTSD to PTSD plus sexual abuse, minors with PTSD following sexual abuse are more likely to suffer MDD, substance use disorder, and suicidal behavior.

The American Journal of Psychiatry presents this review of the most compelling articles that were covered in 2022: The Molecular and Cellular Alterations That Underpin Psychiatric Illnesses Shared and Distinct Neurobiological Mechanisms of PTSD Cognitive Deficits in Long-Term Cannabis Users Longitudinal Outcomes of Duration of Untreated Psychosis Accelerating TMS in the Treatment of Depression Infant Brain Development, Fragile X Syndrome, and Autism Spectrum Disorder Combining Computational Modeling and Postmortem Human Brain Studies to Uncover Synaptic Variability Contributions to Cortical Gamma Oscillation From the AJP Residents’ Journal: Identity and Stigma